Methodist College has partnered with the National Library of Medicine to bring a traveling exhibit to the college, raising ...

The FDA has approved a breakthrough preventative treatment for HIV that could change the course of the AIDS epidemic. But ...

Is the cost of research aimed at curing HIV worth it, when HIV can be effectively managed and prevented by existing drugs?

Thirty-five years ago, the multimillion dollar fundraiser Seventh on Sale propelled the fashion industry into a new era of ...

M orris Singletary’s experience of living with HIV is typical of many gay men. It includes denial, anger, fear and acceptance ...

The National Institutes of Health will phase out its support of the clinical practice guidelines that advise doctors how to ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.

WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday. It’s the first step in an anticipated global rollout that could ...

Of 49 countries surveyed in a recent analysis, 15 have historically relied on the the U.S. for most of the funding for their HIV/AIDS responses. That funding is largely gone now.

A growing coalition of HIV prevention organizations, health experts and Democrats in Congress are sounding the alarm over sweeping Trump administration cuts to HIV/AIDS prevention and surveillance ...

The United States spends around $28 billion on its domestic response to the HIV epidemic, which amounts to roughly one percent of HHS’s fiscal 2025 budget of $2.61 trillion. “I don’t know ...

The HHS infectious-disease office was responsible for coordinating and supporting a policy called Ending the HIV Epidemic in the U.S. and for the Minority HIV/AIDS Fund.